文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

MUC1-C抑制Crb3(一种面包屑复合物极性因子)并下调Hippo信号通路。

MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.

作者信息

Alam Maroof, Bouillez Audrey, Tagde Ashujit, Ahmad Rehan, Rajabi Hasan, Maeda Takahiro, Hiraki Masayuki, Suzuki Yozo, Kufe Donald

机构信息

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

出版信息

Mol Cancer Res. 2016 Dec;14(12):1266-1276. doi: 10.1158/1541-7786.MCR-16-0233. Epub 2016 Sep 22.


DOI:10.1158/1541-7786.MCR-16-0233
PMID:27658423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5136335/
Abstract

UNLABELLED: Apical-basal polarity and epithelial integrity are maintained in part by the Crumbs (CRB) complex. The C--terminal subunit of MUC1 (MUC1-C) is a transmembrane protein that is expressed at the apical border of normal epithelial cells and aberrantly at high levels over the entire surface of their transformed counterparts. However, it is not known whether MUC1-C contributes to this loss of polarity that is characteristic of carcinoma cells. Here it is demonstrated that MUC1-C downregulates expression of the Crumbs complex CRB3 protein in triple-negative breast cancer (TNBC) cells. MUC1-C associates with ZEB1 on the CRB3 promoter and represses CRB3 transcription. Notably, CRB3 activates the core kinase cassette of the Hippo pathway, which includes LATS1 and LATS2. In this context, targeting MUC1-C was associated with increased phosphorylation of LATS1, consistent with activation of the Hippo pathway, which is critical for regulating cell contact, tissue repair, proliferation, and apoptosis. Also shown is that MUC1-C--mediated suppression of CRB3 and the Hippo pathway is associated with dephosphorylation and activation of the oncogenic YAP protein. In turn, MUC1-C interacts with YAP, promotes formation of YAP/β-catenin complexes, and induces the WNT target gene MYC. These data support a previously unrecognized pathway in which targeting MUC1-C in TNBC cells (i) induces CRB3 expression, (ii) activates the CRB3-driven Hippo pathway, (iii) inactivates YAP, and thereby (iv) suppresses YAP/β-catenin-mediated induction of MYC expression. IMPLICATIONS: These findings demonstrate a previously unrecognized role for the MUC1-C oncoprotein in the regulation of polarity and the Hippo pathway in breast cancer. Mol Cancer Res; 14(12); 1266-76. ©2016 AACR.

摘要

未标记:顶-基极性和上皮完整性部分由Crumbs(CRB)复合体维持。MUC1的C末端亚基(MUC1-C)是一种跨膜蛋白,在正常上皮细胞的顶端边界表达,而在其转化对应物的整个表面异常高水平表达。然而,尚不清楚MUC1-C是否导致癌细胞特有的这种极性丧失。本文证明,MUC1-C在三阴性乳腺癌(TNBC)细胞中下调Crumbs复合体CRB3蛋白的表达。MUC1-C与CRB3启动子上的ZEB1结合并抑制CRB3转录。值得注意的是,CRB3激活Hippo通路的核心激酶盒,其中包括LATS1和LATS2。在这种情况下,靶向MUC1-C与LATS1磷酸化增加有关,这与Hippo通路的激活一致,Hippo通路对调节细胞接触、组织修复、增殖和凋亡至关重要。还表明,MUC1-C介导的对CRB3和Hippo通路的抑制与致癌YAP蛋白的去磷酸化和激活有关。反过来,MUC1-C与YAP相互作用,促进YAP/β-连环蛋白复合物的形成,并诱导WNT靶基因MYC。这些数据支持了一条以前未被认识的途径,即在TNBC细胞中靶向MUC1-C(i)诱导CRB3表达,(ii)激活CRB3驱动的Hippo通路,(iii)使YAP失活,从而(iv)抑制YAP/β-连环蛋白介导的MYC表达诱导。 启示:这些发现证明了MUC1-C癌蛋白在乳腺癌极性调节和Hippo通路中以前未被认识的作用。《分子癌症研究》;14(12);1266 - 76。©2016美国癌症研究协会。

相似文献

[1]
MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.

Mol Cancer Res. 2016-12

[2]
Crumbs3-Mediated Polarity Directs Airway Epithelial Cell Fate through the Hippo Pathway Effector Yap.

Dev Cell. 2015-8-10

[3]
ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.

Cancer Sci. 2021-7

[4]
Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.

Cell Signal. 2016-12

[5]
An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.

Oncotarget. 2016-4-26

[6]
Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.

J Exp Clin Cancer Res. 2017-10-10

[7]
Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.

Cancer Res. 2017-7-28

[8]
MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.

Oncogene. 2013-4-15

[9]
GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.

J Hazard Mater. 2018-5-8

[10]
Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.

Oncotarget. 2016-11-22

引用本文的文献

[1]
PP2A Promotes the Symmetric Division of MUC1-Dominant Cancer Stem-Like Cells in Small Cell Lung Cancer.

Adv Sci (Weinh). 2025-7

[2]
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression.

Oncogene. 2024-7

[3]
The Role of MUC1 in Renal Cell Carcinoma.

Biomolecules. 2024-3-7

[4]
Survival-Associated Cellular Response Maintained in Pancreatic Ductal Adenocarcinoma (PDAC) Switched Between Soft and Stiff 3D Microgel Culture.

ACS Biomater Sci Eng. 2024-4-8

[5]
Role of PATJ in stroke prognosis by modulating endothelial to mesenchymal transition through the Hippo/Notch/PI3K axis.

Cell Death Discov. 2024-2-17

[6]
The multifaceted role of MUC1 in tumor therapy resistance.

Clin Exp Med. 2023-9

[7]
Emergence of in Mammals for Adaptation of Barrier Epithelia.

Cancers (Basel). 2022-9-30

[8]
Advances in MUC1-Mediated Breast Cancer Immunotherapy.

Biomolecules. 2022-7-6

[9]
Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells.

J Cancer Metastasis Treat. 2022

[10]
Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.

Theranostics. 2022

本文引用的文献

[1]
MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.

Sci Rep. 2016-5-24

[2]
Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.

Oncotarget. 2016-3-15

[3]
MUC1-C drives MYC in multiple myeloma.

Blood. 2016-5-26

[4]
Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.

Cancer Res. 2016-3-15

[5]
Mechanisms of Hippo pathway regulation.

Genes Dev. 2016-1-1

[6]
Hippo pathway and breast cancer stem cells.

Crit Rev Oncol Hematol. 2016-3

[7]
Hippo pathway and protection of genome stability in response to DNA damage.

FEBS J. 2016-4

[8]
Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target.

PLoS One. 2015-8-12

[9]
Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation.

Clin Cancer Res. 2015-5-15

[10]
MUC1-C activates the TAK1 inflammatory pathway in colon cancer.

Oncogene. 2015-10-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索